186 related articles for article (PubMed ID: 28732436)
1. Downregulation of Aquaporin3 in Systemic Sclerosis Dermal Fibroblasts.
Yousefi B; Mahmoudi M; Sarafnejad A; Karimizadeh E; Farhadi E; Jamshidi AR; Kavosi H; Aslani S; Gharibdoost F
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):228-234. PubMed ID: 28732436
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of aquaporin-3 and epidermal growth factor receptor expression and activation in systemic sclerosis dermal fibroblasts.
Farhadi E; Mahmoudi M; Rahmani F; Yousefi B; Sarafnejad A; Kavosi H; Karimizadeh E; Jamshidi A; Gharibdoost F
J Cell Physiol; 2019 Aug; 234(8):12876-12883. PubMed ID: 30536805
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis.
Yamashita T; Asano Y; Saigusa R; Taniguchi T; Nakamura K; Miura S; Toyama T; Takahashi T; Ichimura Y; Hirabayashi M; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
J Dermatol Sci; 2019 Jan; 93(1):24-32. PubMed ID: 30270117
[TBL] [Abstract][Full Text] [Related]
4. Abnormal collagen V deposition in dermis correlates with skin thickening and disease activity in systemic sclerosis.
Martin P; Teodoro WR; Velosa AP; de Morais J; Carrasco S; Christmann RB; Goldenstein-Schainberg C; Parra ER; Katayama ML; Sotto MN; Capelozzi VL; Yoshinari NH
Autoimmun Rev; 2012 Sep; 11(11):827-35. PubMed ID: 22406224
[TBL] [Abstract][Full Text] [Related]
5. Progranulin Overproduction Due to Fli-1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic Sclerosis.
Ichimura Y; Asano Y; Akamata K; Noda S; Taniguchi T; Takahashi T; Toyama T; Tada Y; Sugaya M; Sato S; Kadono T
Arthritis Rheumatol; 2015 Dec; 67(12):3245-55. PubMed ID: 26245842
[TBL] [Abstract][Full Text] [Related]
6. TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts.
Honda N; Jinnin M; Kajihara I; Makino T; Makino K; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(7):3323-31. PubMed ID: 22379029
[TBL] [Abstract][Full Text] [Related]
7. Dermal tissue and cellular expression of fibrillin-1 in diffuse cutaneous systemic sclerosis.
Wipff J; Avouac J; Le Charpentier M; Varret M; Houtteman A; Ruiz B; Vacher-Lavenu MC; Kahan A; Boileau C; Allanore Y
Rheumatology (Oxford); 2010 Apr; 49(4):657-61. PubMed ID: 20081226
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of CD63 and exosomes in scleroderma dermal fibroblasts.
Nakamura K; Jinnin M; Harada M; Kudo H; Nakayama W; Inoue K; Ogata A; Kajihara I; Fukushima S; Ihn H
J Dermatol Sci; 2016 Oct; 84(1):30-39. PubMed ID: 27443953
[TBL] [Abstract][Full Text] [Related]
9. Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis dermal fibroblasts.
Santiago B; Galindo M; Rivero M; Pablos JL
Arthritis Rheum; 2001 Jul; 44(7):1667-76. PubMed ID: 11465719
[TBL] [Abstract][Full Text] [Related]
10. MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-β activated kinase 1 binding protein 1, implications for systemic sclerosis.
Ciechomska M; O'Reilly S; Suwara M; Bogunia-Kubik K; van Laar JM
PLoS One; 2014; 9(12):e115596. PubMed ID: 25549087
[TBL] [Abstract][Full Text] [Related]
11. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
Reich N; Maurer B; Akhmetshina A; Venalis P; Dees C; Zerr P; Palumbo K; Zwerina J; Nevskaya T; Gay S; Distler O; Schett G; Distler JH
Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
[TBL] [Abstract][Full Text] [Related]
12. Regulatory mechanisms of collagen expression by interleukin-22 signaling in scleroderma fibroblasts.
Sawamura S; Jinnin M; Inoue K; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Ihn H
J Dermatol Sci; 2018 Apr; 90(1):52-59. PubMed ID: 29336866
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-21 and microRNA-29a modulate the expression of collagen in dermal fibroblasts of patients with systemic sclerosis.
Jafarinejad-Farsangi S; Gharibdoost F; Farazmand A; Kavosi H; Jamshidi A; Karimizadeh E; Noorbakhsh F; Mahmoudi M
Autoimmunity; 2019 May; 52(3):108-116. PubMed ID: 31155965
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of ephrins and thrombospondins in the dermis of patients with early diffuse systemic sclerosis: potential contribution to perturbed angiogenesis and fibrosis.
Avouac J; Clemessy M; Distler JH; Gasc JM; Ruiz B; Vacher-Lavenu MC; Wipff J; Kahan A; Boileau C; Corvol P; Allanore Y
Rheumatology (Oxford); 2011 Aug; 50(8):1494-504. PubMed ID: 21454305
[TBL] [Abstract][Full Text] [Related]
16. A reactive oxygen species-mediated loop maintains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis.
Spadoni T; Svegliati Baroni S; Amico D; Albani L; Moroncini G; Avvedimento EV; Gabrielli A
Arthritis Rheumatol; 2015 Jun; 67(6):1611-22. PubMed ID: 25707572
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-29a induces apoptosis via increasing the Bax:Bcl-2 ratio in dermal fibroblasts of patients with systemic sclerosis.
Jafarinejad-Farsangi S; Farazmand A; Mahmoudi M; Gharibdoost F; Karimizadeh E; Noorbakhsh F; Faridani H; Jamshidi AR
Autoimmunity; 2015; 48(6):369-78. PubMed ID: 25857445
[TBL] [Abstract][Full Text] [Related]
18. Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis.
Taniguchi T; Asano Y; Nakamura K; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S
J Rheumatol; 2017 Aug; 44(8):1198-1205. PubMed ID: 28507181
[TBL] [Abstract][Full Text] [Related]
19. High IL-17E and low IL-17C dermal expression identifies a fibrosis-specific motif common to morphea and systemic sclerosis.
Lonati PA; Brembilla NC; Montanari E; Fontao L; Gabrielli A; Vettori S; Valentini G; Laffitte E; Kaya G; Meroni PL; Chizzolini C
PLoS One; 2014; 9(8):e105008. PubMed ID: 25136988
[TBL] [Abstract][Full Text] [Related]
20. Discoidin domain receptor 2-microRNA 196a-mediated negative feedback against excess type I collagen expression is impaired in scleroderma dermal fibroblasts.
Makino K; Jinnin M; Aoi J; Hirano A; Kajihara I; Makino T; Sakai K; Fukushima S; Inoue Y; Ihn H
J Invest Dermatol; 2013 Jan; 133(1):110-9. PubMed ID: 22832484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
